India's Serum Institute to start export of COVID-19 vaccine by year-end

1 minute read
Register now for FREE unlimited access to Reuters.com

May 18 (Reuters) - India's largest vaccine producer Serum Institute on Tuesday said it would continue to scale up its production of AstraZeneca's COVID-19 vaccine and start exporting to other countries by the end of the year.

Register now for FREE unlimited access to Reuters.com
Writing by Susan Mathew in Bengaluru;

Our Standards: The Thomson Reuters Trust Principles.